The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
169 reports and counting
Sana Biotechnology Raises $700M in IPO
Sana Biotechnology, a Biotech company based in 188 East Blaine Street, Seattle, WA 98102, has raised $700M in IPO at a $4.2B valuation led by Flagship Pioneering, ARCH Venture Partners, F-Prime Capital, Baillie Gifford.
Sana Biotechnology raises $700M IPO at $4.2B valuation
Sana Biotechnology raises $700M in IPO at $4.2B valuation. Cell and gene therapy platform...
Sana Biotechnology Raises $300M PIPE
Cell engineering company developing ex vivo and in vivo cell therapies for diabetes, cancer, and genetic diseases
Arbor Biotechnologies Raises $215M in Series C
Arbor Biotechnologies, a Biotech company based in 830 Winter Street, Waltham, MA 02451, has raised $215M in Series C at a $800M valuation led by Lightspeed Venture Partners, Redmile Group, Agent Capital, Amplitude Ventures.
Vir Biotechnology Raises $250M in Series E
Vir Biotechnology, a Biotech company based in 499 Illinois Street, San Francisco, CA 94158, has raised $250M in Series E at a $3.3B valuation led by SoftBank Vision Fund, Arch Venture Partners, ARCH Venture Partners, Intermediate Capital Group.
Arbor Biotechnologies raises $215M Series C at $800M valuation
Arbor Biotechnologies raises $215M in Series C at $800M valuation. Gene editing technologies...
Vir Biotechnology raises $250M Series E at $3.3B valuation
Vir Biotechnology raises $250M in Series E at $3.3B valuation. Infectious disease treatment development...
Sana Benefits Headquarters - Office Location & Address
Discover Sana Benefits's headquarters at Austin, TX. Health benefits platform. Learn about the office facilities and work environment.
Cogent Biosciences Raises $475.3 million in Public Offering
Cogent Biosciences, a Biotechnology company based in Waltham MA, has raised $475.3 million in Public Offering at a Undisclosed led by Public market investors.
Showing 9 reports β’ Page 1 β’ Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.